v3.26.1
Consolidated Statement of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Federal grants $ 5,066,650 $ 5,210,031
Operating expenses:    
Research and development 10,376,895 7,219,437
General and administrative 4,930,701 4,720,728
Total operating expenses 15,307,596 11,940,165
Loss from operations (10,240,946) (6,730,134)
Other income (expense):    
Change in fair value of liability classified warrants 10,096 16,292
Interest expense, net (18,767) (1,290,444)
Other income and expense, net 73,430 17,277
Total other income (expense), net 64,759 (1,256,875)
Net loss (10,176,187) (7,987,009)
Net loss attributable to noncontrolling interests (487) (74)
Deemed dividend related to warrants down round provision 290
Net loss attributable to common stockholders $ (10,175,700) $ (7,987,225)
Net loss per basic and diluted share:    
Net loss per share attributable to common stockholders, basic $ (3.98) $ (11.45)
Net loss per share attributable to common stockholders, diluted $ (3.98) $ (11.45)
Weighted average common shares outstanding, basic 2,557,377 697,686
Weighted average common shares outstanding, diluted 2,557,377 697,686

Source